Patents

Cyngn, an autonomous vehicle technology firm, has been granted U.S. Patent No. 12,332,083 for its modular sensor system designed for automated guided vehicles (AGVs). This marks Cyngn’s 23rd U.S. patent, with 13 granted since August 2023. The system is designed for easy integration with existing industrial machinery, offering adaptability across various industrial machines. Cyngn focuses on AI-powered solutions for industrial environments, aiming to address labor shortages and improve safety.

BYD’s Zhengzhou Speedway opening highlighted China’s dominance in NEV technology. CAIC rankings show Chinese companies, particularly BYD, leading in new energy, hybrid, and pure electric patent authorizations. BYD’s R&D (over 120,000 employees, averaging 45 daily patent filings) drives innovation, including the Blade Battery and advanced hybrid tech. This technological prowess fuels BYD’s sales, with significant domestic and overseas growth, solidifying China’s rising influence in the global NEV market.

On June 23, 2025, Dr Ashleys Limited and Impact BioMedical Inc. announced a merger deal. Dr. Ashleys will acquire Impact BioMedical through a reverse merger, creating a new entity listed on the NYSE American. This strategic alliance merges Impact BioMedical’s innovative patents with Dr Ashleys’ resources and global reach, aiming to expedite the development of impactful therapies and expand global market access for biomedical advancements.